Published in Eur J Cancer on January 05, 2006
The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden. Ann Surg Oncol (2010) 0.95
Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol (2010) 0.84
Confirmation of sentinel lymph node identity by analysis of fine-needle biopsy samples using inductively coupled plasma-mass spectrometry. Ann Surg Oncol (2008) 0.78
Isolated tumor cells and long-term prognosis of patients with melanoma. Ann Surg Oncol (2008) 0.78
Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma. Ann Surg Oncol (2011) 0.76
Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol. BMC Cancer (2017) 0.75
Medical and psychosocial effects of early discharge after surgery for breast cancer: randomised trial. BMJ (1998) 3.90
Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet (1998) 3.28
Randomized clinical trial comparing feeding jejunostomy with nasoduodenal tube placement in patients undergoing oesophagectomy. Br J Surg (2007) 3.05
Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet (2000) 2.84
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg (2012) 2.65
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
[Second Opinion Consult Clinic for Surgical Oncology in the Daniel den Hoed Clinic: analysis of the first 245 patients]. Ned Tijdschr Geneeskd (1999) 2.56
Genetics and biochemistry of the peptidoglycan-associated proteins b and c of Escherichia coli K12. Mol Gen Genet (1979) 2.48
Recombination in Escherichia coli. 3. Mapping by the gradient of transmission. Mutat Res (1970) 2.45
Mapping of a gene for a major outer membrane protein of Escherichia coli K12 with the aid of a newly isolated bacteriophage. Mol Gen Genet (1977) 2.31
Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol (2006) 2.30
Epidemiology of invasive cutaneous melanoma. Ann Oncol (2009) 2.21
Pulmonary resection for metastases of colorectal origin. Chest (1995) 2.09
Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol (1999) 1.99
The dual genetic control of ornithine transcarbamylase synthesis in Escherichia coli K12. Mutat Res (1968) 1.97
[Long-term results of the multidisciplinary surgical treatment of non-small-cell bronchial carcinoma in the superior sulcus (Pancoast tumour): a retrospective study]. Ned Tijdschr Geneeskd (2007) 1.93
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer (2001) 1.91
Genetic recombination in Escherichia coli. I. Relation between linkage of unselected markers and map distance. Mutat Res (1966) 1.87
meoA is the structural gene for outer membrane protein c of Escherichia coli K12. Mol Gen Genet (1979) 1.70
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. Ann Oncol (2013) 1.65
Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer. Br J Surg (2006) 1.65
Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases. Br J Surg (2010) 1.65
Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery. Eur J Surg Oncol (2006) 1.61
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer (2007) 1.58
Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg (2007) 1.57
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST) Eur J Cancer (1999) 1.55
Genetic recombination in Escherichia coli. IV. Isolation and characterization of recombination-deficiency mutants of Escherichia coli K12. Mutat Res (1971) 1.52
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients. J Surg Oncol (2005) 1.52
Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer (2004) 1.52
Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg (1997) 1.48
Safety and efficacy of isolated limb perfusion in elderly melanoma patients. Ann Surg Oncol (2002) 1.46
[Oncoplastic surgery of the breast: a combination of oncological and plastic surgery]. Ned Tijdschr Geneeskd (2007) 1.40
Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary (Br J Surg 2006; 93; 872-878). Br J Surg (2007) 1.40
Metastatic pattern in colorectal cancer is strongly influenced by histological subtype. Ann Oncol (2014) 1.39
Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg (2010) 1.35
Pore protein e of the outer membrane of Escherichia coli K12. FEBS Lett (1978) 1.33
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer (2003) 1.32
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis (2012) 1.30
Genetic recombination in Escherichia coli. II. Calculation of incorporation frequency and relative map distance by recombinant analysis. Mutat Res (1966) 1.30
Soft tissue sarcomas at a glance: clinical, histological, and MR imaging features of malignant extremity soft tissue tumors. Eur Radiol (2009) 1.28
Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation (1998) 1.27
Staging of cutaneous melanoma. Ann Oncol (2009) 1.26
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol (1999) 1.22
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Survival and prognostic factors in BRCA1-associated breast cancer. Ann Oncol (2005) 1.20
A prospective randomized trial of high versus low vacuum drainage after axillary dissection for breast cancer. Am J Surg (1997) 1.19
Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18
Cancer patients seeking a second surgical opinion: results of a study on motives, needs, and expectations. J Clin Oncol (2003) 1.17
Biomarkers in melanoma. Ann Oncol (2009) 1.17
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. Eur J Surg Oncol (2006) 1.15
Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol (2006) 1.13
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg (1999) 1.13
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? Phys Med Biol (2011) 1.10
Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol (1988) 1.10
Motivations, satisfaction, and information of immediate breast reconstruction following mastectomy. Patient Educ Couns (2000) 1.10
Long-term survival and occasional regression of distant melanoma metastases after adrenal metastasectomy. Ann Surg Oncol (2008) 1.09
Small molecules and targeted therapies in distant metastatic disease. Ann Oncol (2009) 1.08
A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. J Thromb Haemost (2012) 1.08
Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg (2015) 1.06
Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg (2006) 1.03
Total pelvic exenteration for primary and recurrent malignancies. World J Surg (2009) 1.02
The pedicled omentoplasty and split skin graft (POSSG) for reconstruction of large chest wall defects. A validity study of 34 patients. Eur J Surg Oncol (1996) 0.97
Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha. Eur J Surg Oncol (2006) 0.96
Continuity of information for breast cancer patients: the development, use and evaluation of a multidisciplinary care-protocol. Patient Educ Couns (1997) 0.96
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol (2007) 0.96
Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96
Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol (2000) 0.96